MR echo case. N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Similar documents
How to assess ischaemic MR?

Professors Carpentier and McGoon Mechanism, resulting from the disease Severity of regurgitation, resulting from the mechanism Echo

Valvular Regurgitation: Can We Do Better Than Colour Doppler?

MITRAL REGURGITATION ECHO PARAMETERS TOOL

Regurgitant Lesions. Bicol Hospital, Legazpi City, Philippines July Gregg S. Pressman MD, FACC, FASE Einstein Medical Center Philadelphia, USA

Disclosures Rebecca T. Hahn, MD, FASE

ASE Guidelines on Aortic Regurgitation What Do I Measure? Case Studies

Marti McCulloch, BS, MBA, RDCS, FASE Houston, Texas

Case Reviews: Hemodynamic Calculations in Valvular Regurgitation

Imaging MV. Jeroen J. Bax Leiden University Medical Center The Netherlands Davos, feb 2015

What echo measurements are key prior to MitraClip?

EVALUATION OF CHRONIC MITRAL REGURGITATION: ASSESSING MECHANISMS AND QUANTIFYING SEVERITY 2018 STRUCTURAL HEART DISEASE CONFERENCE June 1, 2018

Degenerative Mitral Regurgitation: Etiology and Natural History of Disease and Triggers for Intervention

ECHOCARDIOGRAPHY DATA REPORT FORM

Les valvulopathies en sourdine: la valve mitrale Quoi faire devant une régurgitation mitrale sévère asymptomatique de type dégénérative?

Quantification of Aortic Regurgitation

Valve Analysis and Pathoanatomy: THE MITRAL VALVE

Primary Mitral Valve Disease: Natural History & Triggers for Intervention ACC Latin American Conference 2017

What are the best diagnostic tools to quantify aortic regurgitation?

MITRAL STENOSIS. Joanne Cusack

What Degree of MR Deserves Surgical or Transcatheter Intervention, and How Should It Be Assessed?

Primary Mitral Regurgitation

When should we intervene surgically in pediatric patient with MR?

8/31/2016. Mitraclip in Matthew Johnson, MD

Diastolic Heart Function: Applying the New Guidelines Case Studies

Congenital. Unicuspid Bicuspid Quadricuspid

Tricuspid and Pulmonary Valve Disease

DOPPLER HEMODYNAMICS (1) QUANTIFICATION OF PRESSURE GRADIENTS and INTRACARDIAC PRESSURES

Quantification of MR

Σεμινάρια Ομάδων Εργασίας 2017 Ανεπάρκεια μιτροειδούς μυξωματώδους αιτιολογίας

Aortic Stenosis: Spectrum of Disease, Low Flow/Low Gradient and Variants

Tricuspid and Pulmonary Valve Disease

The Doppler Examination. Katie Twomley, MD Wake Forest Baptist Health - Lexington

Prof. JL Zamorano Hospital Universitario Ramón y Cajal

MITRAL VALVE DISEASE- ASSESSMENT AND MANAGEMENT. Irene Frantzis P year, SGUL Sheba Medical Center

ICE: Echo Core Lab-CRF

Hemodynamic Assessment. Assessment of Systolic Function Doppler Hemodynamics

PROSTHETIC VALVE BOARD REVIEW

Exercise Pulmonary Hypertension predicts the Occurrence of Symptoms in Asymptomatic Degenerative Mitral Regurgitation

Doppler Basic & Hemodynamic Calculations

Titel Kardiologie-SG.ch hot topics in heart failure and mitral regurgitation

New 3D Quantification of Mitral Regurgitation Severity. Judy Hung, MD Cardiac Ultrasound Laboratory Massachusetts General Hospital Boston, MA

THE FOLDING LEAFLET. Rafael García Fuster. Cardiac Surgery Department University General Hospital of Valencia

Prosthetic valve dysfunction: stenosis or regurgitation

Valvular Heart Disease: Assessment and Timing of Intervention. Graham Cole Consultant Cardiologist Imperial College Healthcare NHS Trust

Historical perspective R1 黃維立

Clinical Outcome of Tricuspid Regurgitation. David Messika-Zeitoun

25 different brand names >44 different models Sizes mm

Quantification of Mitral Stenosis: Planimetry, pressure Half time, Continuity Common Errors

Cases of mitral valve causing mitral regurgitation: the MV prolapse spectrum CASE

Organic mitral regurgitation

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echo in Asymptomatic Mitral and Aortic Regurgitation

Valvular Heart Disease

Echocardiography. Guidelines for Valve and Chamber Quantification. In partnership with

LUST trial. Echocardiography USER S MANUAL

Outcomes of Mitral Valve Repair for Mitral Regurgitation Due to Degenerative Disease

HEART VALVE DISEASES. Dr. James Kadouch Medical Officer Cardiologist Delphine Labojka Method & Process Manager

TAVR: Echo Measurements Pre, Post And Intra Procedure

CHAPTER 4 AN EFFICACIOUS APPROACH FOR THE QUANTIFICATION OF MITRAL REGURGITATION USING IMAGE PROCESSING AND PROXIMAL FLOW CONVERGENCE METHOD

The difficult patient with mitral regurgitation

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

NEW GUIDELINES. A Guideline Protocol for the Assessment of Aortic Regurgitation From the British Society of Echocardiography Education Committee

좌심실수축기능평가 Cardiac Function

LV geometric and functional changes in VHD: How to assess? Mi-Seung Shin M.D., Ph.D. Gachon University Gil Hospital

Χειρουργική Αντιμετώπιση της Ανεπάρκειας της Μιτροειδούς Βαλβίδας

HEMODYNAMIC ASSESSMENT

Part II: Fundamentals of 3D Echocardiography: Acquisition and Application

School, The University of Texas Health Science Center at Houston, TX.

Adel Hasanin Ahmed 1

Percutaneous Mitral Valve Repair: What Can We Treat and What Should We Treat

Ioannis Alexanian, MD, PhD Department of Cardiology General Hospital of Chest Diseases Sotiria Athens

Quality Outcomes Mitral Valve Repair

Echocardiography: Guidelines for Valve Quantification

Comprehensive Hemodynamics By Doppler Echocardiography. The Echocardiographic Swan-Ganz Catheter.

Dobutamine Stress testing In Low Flow, Low EF, Low Gradient Aortic Stenosis Case Studies

SONOGRAPHER & NURSE LED VALVE CLINICS

AIMI-HF PROCEDURE MANUAL TECHNICAL GUIDE FOR ECHOCARDIOGRAPHY. MHI Core Laboratory E. O Meara - J.C. Tardif J. Vincent, G. Grenier, C.

Transthoracic Echocardiographic

New murmur: acute valvular regurgitations. A.Pasquet, MD,PhD. UCL -Cliniques Saint Luc

Mitral Valve Disorders

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

ΓΙΩΡΓΟΣ ΜΑΚΑΒΟΣ, MD, PhD ΚΑΡΔΙΟΛΟΓΟΣ, ΕΠΙΜΕΛΗΤΗΣ Β Γ ΠΑΝΕΠΙΣΤΗΜΙΑΚΗ ΚΑΡΔΙΟΛΟΓΙΚΗ ΚΛΙΝΙΚΗ Γ.Ν.Ν.Θ.Α. ΣΩΤΗΡΙΑ

Case # 1. Page: 8. DUKE: Adams

Echocardiographic Evaluation of Primary Mitral Regurgitation

P = 4V 2. IVC Dimensions 10/20/2014. Comprehensive Hemodynamic Evaluation by Doppler Echocardiography. The Simplified Bernoulli Equation

Uptofate Study Summary

Ischemic Mitral Regurgitation

Mitral Valve Disease. Prof. Sirchak Yelizaveta Stepanovna

Mitral Valve Disease, When to Intervene

JOINT MEETING 2 Tricuspid club Chairpersons: G. Athanassopoulos, A. Avgeropoulou, M. Khoury, G. Stavridis

Heart Valve disease: MR. AS tough patient When to echo, When to refer, What s new

Aortic Regurgitation & Aorta Evaluation

Cardiac ultrasound protocols

British Society of Echocardiography

Management of TR in Patients Undergoing Mitral Interventions

OPTIMIZING ECHO ACQUISTION FOR STRAIN AND DIASTOLOGY

imagine 2018 Echocardiography Today - Do, Learn, Do More, Learn More November 3-4, 2018 Georgia Technology Hotel and Conference Center

Stress Testing in Valvular Disease

Milind Desai Christine Jellis Teerapat Yingchoncharoen Editors. An Atlas of Mitral Valve Imaging

Transcription:

MR echo case N.Koutsogiannis Department of Cardiology University Hospital Of Patras

Case A 35 years old male came to the echo lab for a third opinion for his valvulopathy. He reports a long standing MR and fatigue during the last two years. He had already scheduled surgery for his valvulopathy based on the opinion of his physician and a second opinion from an experienced hospital doctor.

His Valve

His MR

Questions 1) What is wrong with his valve? 2) Is his MR severe? 3) Does he needs surgery to correct it?

A systematic approach is the key for every valvulopathy Look at the Valve first!! (Aetiology, lesions, mechanism) Define the severity Define the consequences on cardiac champers and pulmonary circulation Explain the symptoms of the patient

Prolapse Flail leaflet Rheumatic Look at the valve first!! (Aetiology,lesions, mechanism) Functional Annular calcification Endocarditis SAM Mitral Cleft

Carpentier s Functional Classification Type I Normal leaflet mobility Φυσιολογική κινητικότητα των γλωχίνων Annular dilatation (DCM, Ischemic CMR, Chronic AF) Leaflet perforation (endocarditis) Congenital abnormalities Type II Excessive leaflet mobility Αυξημένη κινητικότητα των γλωχίνων Leaflet prolapse (degenerative) Flail leaflet (degenerative, endocarditis,ruptured PM in MI) Type III Restricted leaflet mobility Περιορισμένη κίνηση των γλωχίνων Both in diastole and systole (Rheumatic, radiation) In systole (DCM, Ischemic CMP) ΙΙΙα IIIb

Is it the Valve or the Ventricle? Increased EF = Organic MR Reduced EF = Functional MR Treat the Valve! Treat the Ventricle!

Based on Carpentier s functional classification what is the mechanism and the aetiology of MR in the case? 1) Normal leaflet mobility-annular dilatation 2) Excessive leaflet mobility-degenerative mitral disease 3) Excessive leaflet mobility-endocarditis 4) Restricted leaflet mobility-functional MR

The case Excessive leaflet mobility with normal EF Degenerative Valve disease

Degenerative mitral valve disease 2% of the population - 60-70% of mitral valve surgery Age > 60 years short history of MR due to rupture of chordae ( typical of P2 segment) normal size of normal or thin leaflets normal annular size Age < 60 years long history of MR due to chordal elongation and leaflet prolapse large thick leaflets large annular size

Phenotype presentation of degenerative valve disease in the patient Barlow s disease Excessive leaflet tissue (floppy valve) Valve prolapse Annular dilatation Large posterior leaflet

Parasternal long axis Classical view Medium portion A2 P2 segments Tilting toward aorta Anterolateral portion A1 P1 segments Tilting toward tricuspid Posteromedial portion A3 P3 segments

TTE 4-Champer View Tilting upward Anterolateral portion A1 P1 segments Classical view Medium portion A2 P2 segments Tilting downward Posteromedial portion A3 P3 segments

Short axis view Systole: Localization of prolapse by localization of the origin of the regurgitant jet

Questions Degenerative Barlow s disease with most affected the anterolateral segment(s) 1) What is wrong with his valve? 2) Is his MR severe? 3) Does he needs surgery to correct it?

Moderate MR can be tolerated indefinitely Progression of organic MR is variable and determined by progression of lesions (most often a new flail leaflet) and/or annular dilatation

Severity of MR Is the valve flail? Case A flail valve If you see a flail segment the MR is SEVERE

Color Flow imaging Beware of the PISA Look upstream for PISA with normal settings.if you see it quantify the degree of MR

If the PISA dosen t seems HOLOSYTOLIC do a color M-mode Functional MR Degenerative MR Variation of ERO (and PISA) during systole in the different forms of MR Rheumatic MR

If we measure the end-systolic PISA in the case the ERO is 57mm² witch indicates SEVERE MR

Based on end-systolic PISA calculation for ERO,the MR in the case is: 1) Severe (because ERO > 40mm²) 2) Moderate (because the PISA is end-systolic) 3) We need also the time duration of end-systolic PISA to conclude about MR severity 4) We can not use PISA for the calculation of ERO

When PISA is not holosystolic:

A peak E velocity > 1,5 m/sec suggests severe MR (in the absense of MS) A dominant A wave basically excludes severe MR Case E wave 1,1 m/sec No systolic reversal in pulmonary veins PW Doppler Systolic reversal in pulmonary veins in severe MR

Mitral to aortic Time velocity integral (TVI) TVI ratio = Mitral TVI / Aortic TVI TVI ratio > 1,4 in severe MR TVI ratio < 1 in mild MR Case ratio = 1

Doppler Volumetric method (when pisa-method of vena contracta is not applicable ) Calculation of LVOT stroke volume LVOT SV = LVOT ² X 0,785 X LVOT TVI Case RegVolume = 56ml ERO=30mm² Calculation of mitral inflow stroke volume MV SV = Mitral annulus ² X 0,785 X MV TVI Regurgitant Volume = MV SV LVOT SV EROA = Reg Vol / MR TVI Time consuming multiple calculations (and possible errors)

CW Doppler In severe MR Dense MR signal Early peak Triangular contour LOW MAX VELOCITY High Max Velocity means LOW LEFT ATRIAL and WEDGE PRESSURES

Consequences LVEF = 68% ESD = 38mm LV dilatation and systolic dysfunction RVSP =40mmHg Pulmonary hypertension

Questions Degenerative Barlow s disease with most affected the anterolateral segment(s) 1) What is wrong with his valve? 2) Is his MR severe? No it is Moderate 3) Does he needs surgery to correct it?

50% of patients with SEVERE organic MR will need surgery in the next 8 years Moderate Severe How many years before the clock start clocking? But the patient is here Rosenhek Circulation 2006

The patient visited the surgery center and after a Transesophageal echo the Surgeon told him that his condition is severe and he should repair the valve

Don t ask the butcher these questions: Is it good to eat meat? Have you got good meat? Should I buy now?